{
  "id": 2073037,
  "title": "Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines",
  "url": "https://urgent.news/2026/08/20/skin-cancer-breakthrough-delivers-second-act-for-modernas-mrna-2073037",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T03:51:01.000Z",
  "source": {
    "name": "The National Business",
    "slug": "the-national-business",
    "url": "https://www.thenationalnews.com/news/uae/2026/08/20/skin-cancer-breakthrough-delivers-second-act-for-modernas-mrna-vaccines/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A personalised vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. The trial met its main goal as the vaccine, combined with Merck’s immune drug Keytruda, prevented the cancer’s return after it was surgically removed more…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The National UAE",
        "title": "Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines",
        "url": "https://urgent.news/2026/08/20/skin-cancer-breakthrough-delivers-second-act-for-modernas-mrna",
        "published": "2026-08-20T03:51:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}